Vor Bio to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Vor Bio (Nasdaq: VOR), a leader in cell and genome engineering, is set to participate in several important investor conferences. The events include:

• Chardan's 7th Annual Genetic Medicines & Cell Therapy Manufacturing Virtual Summit on April 24, 2023, at 9:30 am ET.
• H.C. Wainwright BioConnect Investor Conference on May 2, 2023, at 12:00 pm ET, located at Nasdaq World Headquarters, New York, NY.
• The JMP Securities Life Sciences Conference on May 16, 2023, at 3:00 pm ET, taking place at New York Hilton Midtown.

Live webcasts and archived replays of these sessions will be accessible on their investor relations website.

Vor Bio focuses on enhancing treatment options for blood cancer patients through innovative stem cell engineering.

CAMBRIDGE, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

Chardan's 7th Annual Genetic Medicines & Cell Therapy Manufacturing Virtual Summit
Fireside Chat: Monday, April 24, 2023 at 9:30 am ET

H.C. Wainwright BioConnect Investor Conference
Fireside Chat: Tuesday, May 2, 2023 at 12:00 pm ET
Location: Nasdaq World Headquarters, New York, NY

The JMP Securities Life Sciences Conference
Fireside Chat: Tuesday, May 16, 2023 at 3:00 pm ET
Location: New York Hilton Midtown, New York, NY

A live webcast and archived replay of the fireside chats will be available on the investors section of our website, linked here: https://ir.vorbio.com/events-presentations/

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Investors & Media
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com

FAQ

What investor conferences is Vor Bio participating in April and May 2023?

Vor Bio will participate in Chardan's Genetic Medicines Summit on April 24, H.C. Wainwright BioConnect on May 2, and JMP Securities Life Sciences Conference on May 16, 2023.

When is Vor Bio's fireside chat at the Chardan Summit?

Vor Bio's fireside chat at Chardan's Summit is scheduled for April 24, 2023, at 9:30 am ET.

Where will the H.C. Wainwright BioConnect Conference be held?

The H.C. Wainwright BioConnect Conference will be held at Nasdaq World Headquarters in New York, NY.

How can I access Vor Bio's investor conference webcasts?

Webcasts of Vor Bio's investor conferences will be available live and as archived replays on their investor relations website.

What is Vor Bio's focus in the healthcare sector?

Vor Bio specializes in cell and genome engineering to improve treatment options for patients with blood cancers.